Evidence map›Paper›PMID 24211092›Full record

ArticleAtencion primaria2014

[Medical students and drug marketing].

Sara Calderón Larrañaga, María José Rabanaque Hernández

Abstract readEnglish Abstract
In one paragraph

Article in Atencion primaria, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sara Calderón LarrañagaMedicina de Familia y Comunitaria, Centro de Salud Universitario Cartuja, Distrito Sanitario Granada, Servicio Andaluz de Salud, Granada, España. Electronic address: sarakalde@gmail.com.
María José Rabanaque HernándezDepartamento de Microbiología, Medicina Preventiva y Salud Pública, Facultad de Medicina, Universidad de Zaragoza, Instituto Aragonés de Ciencias de la Salud, Zaragoza, España.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo determine the exposure of medical students to the marketing activities of the pharmaceutical industry, and identify their opinions and attitudes, and also the possible effects this exposure on their training and future professional practice.

designDescriptive cross-sectional.

settingUniversity of Zaragoza Faculty of Medicine.

participantsThird, fourth, fifth and sixth year medical students.

methodsThe information was obtained using a previously adapted, self-report questionnaire on the exposure, attitudes and perceived suitability of drug marketing activities. Percentages were calculated for the categorical variables, applying the chi squared test for the comparison between the groups. A logistic regression was performed to determine the factors associated with their attitudes towards these activities.

resultsA total of 369 questionnaires were returned (93% of those attending classes). The exposure to marketing activities is high, particularly in the clinical stage (78.6% said to have received a gift non-educational gift). The students recognised the possible biases and repercussions in professional practice, although with ambiguity and contradictions. The most accepted activities are those associated with training, and the most critical attitudes appear in the clinical stage, particularly in the sixth year.

conclusionsExposure to drug marketing by medical students and its possible training and professional effects is frequent and significant. The training environment is particularly open to promotional activities. The differences observed in the later years suggest the need for a specific curriculum subject and development of reflective attitudes by the students themselves.

Indexed as

AttitudeDrug IndustryMarketingStudents, MedicalAdultCross-Sectional StudiesFemaleHumansMaleSurveys and QuestionnairesConflicto de interesesConflict of interestsEstudiantes de medicinaÉtica médicaIndustria farmacéuticaMarketingMedical ethicsMedical studentsPharmaceutical industry

Identifiers

PMID24211092
PMCPMC6985649

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.